These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5097966)

  • 1. Drugs for Ceylon.
    Br Med J; 1971 Sep; 3(5777):724. PubMed ID: 5097966
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceuticals management in Ceylon.
    Wickremasinghe SA; Bibile S
    Br Med J; 1971 Sep; 3(5777):757-8. PubMed ID: 5097971
    [No Abstract]   [Full Text] [Related]  

  • 3. Essential drugs for developing countries.
    Ceylon Med J; 1978; 23(2-3):41-4. PubMed ID: 263408
    [No Abstract]   [Full Text] [Related]  

  • 4. The political economy of controlling transnationals: the pharmaceutical industry in Sri Lanka, 1972-1976.
    Lall S; Bibile S
    Int J Health Serv; 1978; 8(2):299-328. PubMed ID: 640768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexities of equitable drug availability.
    Sheridan DJ
    Lancet; 2004 Apr; 363(9417):1327. PubMed ID: 15094288
    [No Abstract]   [Full Text] [Related]  

  • 6. EU agrees deal on cheaper drugs for developing world.
    Watson R
    BMJ; 2003 Jun; 326(7401):1229. PubMed ID: 12791716
    [No Abstract]   [Full Text] [Related]  

  • 7. Access to essential drugs.
    Dev World Bioeth; 2001 Nov; 1(2):89-92. PubMed ID: 12870517
    [No Abstract]   [Full Text] [Related]  

  • 8. Philippines joins other developing countries in limiting prices of drugs.
    Bland B
    BMJ; 2009 Aug; 339():b3151. PubMed ID: 19651688
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug studies in developing countries.
    Olliaro PL; Vijayan R; Inbasegaran K; Lang CC; Looareesuwan S
    Bull World Health Organ; 2001; 79(9):894-5. PubMed ID: 11584742
    [No Abstract]   [Full Text] [Related]  

  • 10. UK leads initiative to drive down cost of drugs in poor countries.
    Short R
    BMJ; 2007 Apr; 334(7599):870. PubMed ID: 17463440
    [No Abstract]   [Full Text] [Related]  

  • 11. Second drug firm found guilty of "switching" patients to new drugs.
    Kmietowicz Z
    BMJ; 2004 Oct; 329(7471):875. PubMed ID: 15485945
    [No Abstract]   [Full Text] [Related]  

  • 12. More drugs, less protection.
    Nature; 2002 Sep; 419(6904):233. PubMed ID: 12239521
    [No Abstract]   [Full Text] [Related]  

  • 13. Use caution when donating drugs, guidelines suggest.
    Riggs B
    CMAJ; 1990 Jan; 142(1):65-6. PubMed ID: 2293855
    [No Abstract]   [Full Text] [Related]  

  • 14. Sparks fly over patents and vital drugs at world health assembly.
    Kapp C
    Lancet; 2003 May; 361(9372):1873. PubMed ID: 12788578
    [No Abstract]   [Full Text] [Related]  

  • 15. Europe's drug companies are better than those in US in making drugs accessible to poor countries.
    Jack A
    BMJ; 2008 Jun; 336(7658):1396. PubMed ID: 18566062
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of the State Pharmaceuticals Corporation of Sri Lanka.
    Jayewardene LG
    Ceylon Med J; 1980; 25(3-4):96-101. PubMed ID: 7185498
    [No Abstract]   [Full Text] [Related]  

  • 17. [On misery coast. Episode 1: the market of vital drugs].
    Chneiweiss H
    Med Sci (Paris); 2003; 19(8-9):892-4. PubMed ID: 14593623
    [No Abstract]   [Full Text] [Related]  

  • 18. An audience with...Sir John Sulston.
    Sulston J
    Nat Rev Drug Discov; 2005 Feb; 4(2):98. PubMed ID: 15756755
    [No Abstract]   [Full Text] [Related]  

  • 19. TRIPS, pharmaceuticals, developing countries, and the Doha "solution".
    Sykes AO
    Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299
    [No Abstract]   [Full Text] [Related]  

  • 20. Making drugs, not profits.
    Stix G
    Sci Am; 2004 May; 290(5):42-4. PubMed ID: 15127660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.